961.14(4)(tr)
(tr) JWH-081: 1-pentyl-3-(4-methoxy-1-naphthoyl)indole, also known as 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone.
961.14(4)(tu)
(tu) JWH-200: 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole.
961.14(4)(ty)
(ty) JWH-250: 1-pentyl-3-(2-methoxyphenylacetyl)indole, also known as 2-(2-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone.
961.14(4)(u)
(u) 1-[1-(2-thienyl)cyclohexyl]piperidine, which is the thiophene analog of phencyclidine;
961.14(4)(ud)
(ud) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thiophene pyrrolidine analog of phencyclidine;
961.14(4)(ug)
(ug) N-ethyl-1-phenylcyclohexylamine, which is the ethylamine analog of phencyclidine;
961.14(4)(ur)
(ur) 1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrrolidine analog of phencyclidine;
961.14(4)(w)
(w) 4-bromo-2,5-dimethoxyamphetamine, commonly known as "DOB";
961.14(4)(wg)
(wg) 4-bromo-2,5-dimethoxy-beta-phenylethylamine, commonly known as "2C-B" or "Nexus";
961.14(4)(wgm)
(wgm) 4-iodo-2,5-dimethoxy-beta-phenylethylamine, commonly known as "2C-I".
961.14(4)(wh)
(wh) 2,5 dimethoxy-4-(n)-propylthiophenethylamine, commonly known as "2C-T-7";
961.14(4)(wi)
(wi) Alpha-methyltryptamine, commonly known as "AMT";
961.14(4)(wj)
(wj) 5-methoxy-N, N-diisopropyltryptamine, commonly known as "5-MeO-DIPT";
961.14(4)(x)
(x) 4-methoxyamphetamine, commonly known as "PMA."
961.14(5)
(5) Depressants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(5)(ag)
(ag) Gamma-hydroxybutyric acid (commonly known as gamma hydroxybutyrate or "GHB"), gamma-butyrolactone, and 1,4-butanediol.
961.14(6)
(6) Immediate precursors. Any material, compound, mixture or preparation which contains any quantity of any of the following substances or their salts:
961.14(7)
(7) Stimulants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their precursors, analogs, salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(7)(m)
(m) Methylenedioxypyrovalerone, commonly known as "MDPV."
961.14(7)(n)
(n) 4-methylmethcathinone, commonly known as "mephedrone" or "4-MMC."
961.14(7)(p)
(p) 4-methylthioamphetamine, commonly known as "4-MTA."
961.14(7)(q)
(q) N- benzylpiperazine, commonly known as "BZP."
961.14 History
History: 1971 c. 219;
1981 c. 206; CSB 2.16, 2.15, 2.17, 2.18, 2.19, 2.20;
1989 a. 121; CSB 2.21;
1993 a. 98,
118; CSB 2.22;
1995 a. 225;
1995 a. 448 ss.
157 to
165; Stats. 1995 s. 961.14;
1997 a. 220;
1999 a. 21;
2001 a. 16;
2005 a. 52; CSB 2.31, 2.32, 2.33, 2.34;
2011 a. 31; s. 35.17 correction in (4) (wgm).
961.14 Note
NOTE: See 1979-80 Statutes and 1993-94 Statutes for notes on actions by controlled substances board under s. 161.11 (1), 1993 Stats.
961.14 Annotation
A chemical test need not be specifically for marijuana in order to be probative beyond a reasonable doubt. State v. Wind,
60 Wis. 2d 267,
208 N.W.2d 357 (1973).
961.14 Annotation
Stems and branches supporting marijuana leaves or buds are not "mature stalks" under sub. (14). State v. Martinez,
210 Wis. 2d 396,
563 N.W.2d 922 (Ct. App. 1997),
96-1899.
961.15
961.15
Schedule II tests. 961.15(1m)(1m) The controlled substances board shall add a substance to schedule II upon finding that:
961.15(1m)(b)
(b) The substance has currently accepted medical use in treatment in the United States, or currently accepted medical use with severe restrictions; and
961.15(1m)(c)
(c) The abuse of the substance may lead to severe psychological or physical dependence.
961.15(2m)
(2m) The controlled substances board may add a substance to schedule II without making the findings required under
sub. (1m) if the substance is controlled under schedule II of
21 USC 812 (c) by a federal agency as the result of an international treaty, convention or protocol.
961.15 History
History: 1971 c. 219;
1995 a. 448 ss.
166,
167,
472; Stats. 1995 s. 961.15.
961.16
961.16
Schedule II. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule II:
961.16(2)
(2) Substances of plant origin. Any material, compound, mixture or preparation which contains any quantity of any of the following substances in any form, including a substance contained in a plant, obtained from a plant, chemically synthesized or obtained by a combination of extraction from a plant and chemical synthesis:
961.16(2)(a)
(a) Opium and substances derived from opium, and any salt, compound, derivative or preparation of opium or substances derived from opium. Apomorphine, dextrorphan, nalbuphine, butorphanol, nalmefene, naloxone and naltrexone and their respective salts and the isoquinoline alkaloids of opium and their respective salts are excluded from this paragraph. The following substances, and any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation, are included in this paragraph:
961.16(2)(a)1.
1. Opium, including raw opium, opium extracts, opium fluid extracts, powdered opium, granulated opium and tincture of opium.
961.16(2)(a)3.
3. Concentrate of poppy straw, which is the crude extract of poppy straw in either liquid, solid or powder form containing the phenanthrene alkaloids of the opium poppy.
961.16(2)(b)
(b) Coca leaves and any salt, compound, derivative or preparation of coca leaves. Decocainized coca leaves or extractions which do not contain cocaine or ecgonine are excluded from this paragraph. The following substances and any of their salts, esters, isomers and salts of esters and isomers that are theoretically possible within the specific chemical designation, are included in this paragraph:
961.16(3)
(3) Synthetic opiates. Any material, compound, mixture or preparation which contains any quantity of any of the following synthetic opiates, including any of their isomers, esters, ethers, esters and ethers of isomers, salts and salts of isomers, esters, ethers and esters and ethers of isomers that are theoretically possible within the specific chemical designation:
961.16(3)(m)
(m) Meperidine — Intermediate — A, 4-cyano-1-methyl-4- phenylpiperidine;
961.16(3)(n)
(n) Meperidine — Intermediate — B, ethyl-4-phenylpiperidine- 4-carboxylate;
961.16(3)(p)
(p) Meperidine — Intermediate — C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
961.16(3)(s)
(s) Methadone — Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenylbutane;
961.16(3)(t)
(t) Moramide — Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropanecarboxylic acid;
